Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Sorafenib + Everolimus for Thyroid Cancer
Recruiting1 awardPhase 2
Sleepy Hollow, New York
This trial is testing whether adding everolimus to sorafenib tosylate helps treat patients with radioactive iodine refractory thyroid cancer better than sorafenib tosylate alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service